Apollo Hospitals Enterprise enterprise value

·Pharma & HealthChart ›
MultiplesEnterprise valuePer share
Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
1,17,916————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
1,8281,8282,0101,190726
494494441385334
5,6595,6595,2753,1622,710
1,22,241————
3,8313,8313,2651,9721,985
₹8,500.77————
15,63315,63313,92810,4829,242
36.2%36.2%37.9%30.2%29.3%
0.05×————
4.63×————
30.49×————
39.27×————
136.78×————
Reference items — trailing FY values
26,43025,22921,79419,05916,612
4,0103,7693,0222,3912,050
3,1132,8932,2641,7041,434
—2,8562,1361,9201,377
894894424784249
—824343684192
—1,9621,7131,1371,129
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

APOLLOHOSP₹8,200.00

Apollo Hospitals Enterprise Ltd.

· Pharma & Health
₹ CrorePeersFORTISMAXHEALTHMEDANTASUNPHARMACIPLADRREDDYDIVISLABTORNTPHARMMcap ₹1.18L Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————1,17,916.0
- Cash, Equiv & ST Investments725.61,189.52,010.41,827.81,827.8
+ Minority Interest334.1385.1440.6494.4494.4
+ Total Debt2,710.33,161.95,275.25,658.55,658.5
Enterprise Value————1,22,241.1
Net Debt (memo)1,984.71,972.43,264.83,830.73,830.7
EV per Share————8,500.77
Total Capital9,241.610,482.413,928.115,633.015,633.0
Total Debt/Total Capital29.3330.1637.8736.2036.20
Total Debt/EV————0.05
EV/Sales————4.63
EV/EBITDA————30.49
EV/EBIT————39.27
EV/Free Cash Flow————136.78
Reference Items — Trailing FY Values
Sales16,612.519,059.221,794.025,228.526,429.9
EBITDA2,049.62,390.73,021.83,769.34,009.5
EBIT1,434.41,703.72,264.32,893.23,113.0
Operating Cash Flow1,377.11,920.32,136.42,855.7—
Free Cash Flow248.5783.5423.7893.7893.7
FCFF (free cash flow to the firm)192.2684.5343.3823.9—
Capital Expenditure1,128.51,136.81,712.71,962.0—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 145%.